Clinical Trials Browser

Phase 2 × Locally Recurrent Rectal Cancer × Irinotecan × Clear all

NCT06928584 2025-04-15

Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer

Phase 2 Recruiting

Gastrointestinal

Locally Recurrent Rectal Cancer